Her2-positive breast cancer in a young patient with Li-Fraumeni syndrome: A comprehensive case study
Managing Li-Fraumeni syndrome (LFS) and its associated cancers, particularly in young patients, necessitates a comprehensive and multidisciplinary approach. Early genetic testing for TP53 mutations is crucial in identifying LFS, enabling personalized treatment plans and proactive surveillance strategies.
Authors
- Priscilla Strom
- Mena Louis (ORCID: https://orcid.org/0009-0007-5446-9743)
- Nathaniel Grabill (ORCID: https://orcid.org/0000-0002-2046-1408)
- Hardeep Singh (ORCID: https://orcid.org/0000-0001-7929-8804)
- Jerrell Fang
Institutions
- Northeast Georgia Medical Center (US)
- Breast Center (CH)
Publication Details
- Journal
- International Journal of Surgery Case Reports
- Published
- 2024-09-19
- DOI
- https://doi.org/10.1016/j.ijscr.2024.110323
- Primary Topic
- Cancer-related Molecular Pathways
- Type
- article
- Field-Weighted Citation Impact
- 0.00